By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

BioDelivery Sciences International 

2501 Aerial Center Parkway
Suite 205
Morrisville  North Carolina  27560  U.S.A.
Phone: 919-651-5160 Fax: 919-651-5161


SEARCH JOBS


Industry
Biotechnology

Segment
Drug Delivery





Company News
BioDelivery (BDSI) To Present Three Posters On BELBUCA And BUNAVAIL At PAINWeek 2017 8/17/2017 6:30:30 AM
BioDelivery (BDSI) Publishes Shareholder Letter With Mid-Year Corporate Update 7/31/2017 12:27:07 PM
BioDelivery (BDSI) To Host Conference Call And Webcast Reporting 7/28/2017 9:16:15 AM
BioDelivery (BDSI) Signs Exclusive Agreement With Purdue Pharma L.P. (Canada) For The Licensing And Distribution Rights Of Belbuca In Canada 7/12/2017 9:00:35 AM
BioDelivery (BDSI) Announces Health Canada Approval Of BELBUCA 6/23/2017 6:59:28 AM
BioDelivery (BDSI) Announces Agreement With CVS/Caremark For BELBUCA And BUNAVAIL Through 2020 6/21/2017 8:22:49 AM
BioDelivery (BDSI) Reports First Quarter 2017 Financial Results And Provides Corporate Update 5/16/2017 10:28:46 AM
BioDelivery (BDSI): ~$2 Biopharma Stock On The Cusp Of A Turnaround 5/12/2017 6:30:37 AM
BioDelivery (BDSI) To Host Conference Call And Webcast Reporting First Quarter 2017 Financial Results On Monday, May 15 5/9/2017 11:39:44 AM
BioDelivery (BDSI) Announces The Approval Of BUNAVAIL For Induction Of Buprenorphine Treatment For Opioid Dependence 5/2/2017 6:16:33 AM
12345678910...
//-->